[Objective] Discussion on academic ideas and clinical experience of Professor Fu Ping in treatment of polycystic ovary syndrome. [Methods] From the etiology and pathogenesis, therapeutic principle and therapy to expound the academic viewpoints and clinical experience of Professor Fu Ping in treatment of polycystic ovary syndrome, the prescription and Chinese medicine conditioning characteristics are summarized, and exemplify that. [Results] Professor Fu Ping believes that the pathogenesis of this disease is a virtual reality, such as phlegm and blood stasis;according to the etiology and pathogene-sis, strengthening the body resistance to eliminate pathogenic factors, coordinating Chong and Conception Vessels is the main rule; dissipating phlegm and removing dampness, warming the kidney and strengthening the spleen, nourishing liver kidney, regulating qi and activating blood is the clinical common therapy, clinical y obtaining better therapeutic effect. [Conclusion] The clinical experience of Professor Fu Ping in treatment of polycystic ovary syndrome is effective, has the value of popularization and application.

Acquired Immunodeficiency Syndrome ; prevention & control ; Humans

Objective:To explore the necessity of monitoring polysomnography (PSG ) in snoring children.Method:The PSG were monitored in 162 children with snoring or apnea.Acording to results of PSG,162 cases were separated into two groups:group obstructive sleep apnea hypopnea syndrome(OSAHS) and group primary snoring(PS),monitoring data including:apnea hypopnea index(AHI),snoring index(SI),lowest oxygen saturation(LSaO_2) and time of SaO_2<0.9,all data were undertaked statistical analysis. Result:In all 162 snoring cases,150 cases(92.6%) belong to group OSAHS,12 cases(7.4%) belong to group PS;Differences of data of age,sex and body mass index(BMI) are not significant but that of AHI,SI,LSaO_2 and time of SaO_2<0.9 are significant(P<0.05).Conclusion:It's necessary to monitor PSG in snoring children for early diagnosis and correct treatment to avoid disadvantage of OSAHS.

Objective To assess the pulmonary function before liver transplantation in patients with end-stage liver disease. Methods One hundred and fifty-four patients with end-stage liver disease, who were waiting for liver transplantation in our hospital, were enrolled into the study. The pulmonary ventilation function,small airway function and diffusion capacity were measured and analyzed respectively. Results Among 154 subjects,140 (90. 9%, 140/154) patients had abnormal pulmonary function, shown as pulmonary diffusing capacity reduction;followed by restrictive ventilatory function reduction (42. 8% ,66/154) and small airway function reduction (37. 7%, 58/154 ), the least common manifestation was obstructive ventilatory function reduction (28.6 % ,44/154 ). Conclusion Abnormal pulmonary function in patients with end-stage liver disease is common, and the pulmonary function tests before liver transplantation has certain referential value for pulmonary function damage evaluation and postoperatively respiratory tract management.

Objective To evaluate the role of the fractional dilatation and curettage (D&C) in the diagnosis of atypical hyperplasia of endometrium. Methods The retrospective analysis was performed in 48 patients diagnosed as atypical hyperplasia of endometrium and treated in our hospital from Aug.2009 to Dec.2010. We compared the pathology results of D&C with hysterectomy specimens, and investigated the reasons for the difference. Results The six patients (12.5%) with mild atypical hyperplasia of endometrium still presented with significant pathological changes after D&C (χ2 = 5.90, P＜0.05), 11 cases (22.9%) in 14 patients(29.2%) with moderate atypical hyperplasia (χ2=0.49, P＞0.01), 18 cases (100%) in patents with serious atypical hyperplasia, among which even 8 patients (44.4%) were verified as endometrial cancer. Conclusions There exists pathological discrepancy between the fractional D&C and hysterectomy specimens. Patients with severer atypical hyperplasia may have a higher risk of developing endometrial cancer.

With the advance of modern neonatal management, the increase of survival of infants born with ELBW has resulted in collateral increase in incidence of infants with serious chronic lung disease, typically brnchopulmonary dysplasia (BPD). Long-term sensory, motor and cognitive impairments are common outcomes in survivals with moderate and severe BPD and may persist during school years and adolescence. Increasing evidence suggest that BPD exerts a significant effect on brain growth and development and may be associated with chronic sublethal hypoxia which compond the risk of extended brain injury and NS complications such as cerebral palsy. Animal studies have demonstrated progressive gliosis and cerebral ventriculomegaly, injured subcortical white matter and corpus callosum, dysynchrony synaptic development and disrupted neurotransmitssion in the hypoxia newborn brain. In this literature we built upon the review of neurogical and congnitive outcome in preterm infants with BPD and structural, functional and neurochemical alterations in ainimals following clinical and experimental hypoxia respectively, which may underlie the primary or potential mle for chronic sublethal hypoxia on premature brain development.

Objective To observe the effects of aspirin on PCNA and cyclin D1 expressions in diethylnitrosamine (DEN) induced hepatic cancer of the rat. Methods Sprague-Dawley (SD) rats were randomly divided into DEN group and DEN plus aspirin group. Each group was further divided into 8,12,16 week subgroups. The expressions of PCNA and cyclin D1 in hepatic tissue were examined with inmunohistochemistry. Results In DEN plus aspirin group cirrhosis was less severe and carcinoma developed later than that in DEN group. Hepatic carcinoma occurred in four rats out of six in DEN group at the 16th week (P<0.05). In DEN plus aspirin group PCNA and cyclin D1 expressions were significantly lower than those in DEN group(P <0.05) , inhibiting effects on cyclin D1 expression was evidently great at 16th week (F=11.944,P<0.05) and inhibiting effect on PCNA was obvious from 12th to 16th week (F=5.696 and F=11.057, P<0.05 ). Conclusion Aspirin downregulates the expressions of PCNA and cyclin D1 in hepatic tissues and inhibits the genesis and development of DEN induced hepatic cancer of the rats.

From information and consent,the article explores the history,connotation,element and the problems encountered in practice of informed consent.The paper aims to provide help for resolving realitical problems by these theoretical discussion.

Objective To observe the effects of Shengqing Chinese herbs on the obesity and leptin resistance of diet-induced obesity (DIO) rats.Methods Wistar rats were produced a rat model including of 40 DIO rats and 10 DIO-R rats. The DIO rats were divided into DIO model group, sibutramine group, Jianpi Liqi group and Shengqing group, which were respectively by gavage of saline, sibutramine, Jianpi Liqi herbs (Citri reticulatae pericarpium, Aucklandiae radix, Aurantii fructus immaturus), Shengqing herbs (Bupleuri radix, Cimicifugae rhizoma, Puerariae lobatae radix), blank control group and DIO-R group were by gavage of saline. Their weight, were examined after 16 weeks gavage. Leptin and neuropeptide Y in the serum were examined. Leptin, TNF-α, and suppressors of cytokine signaling-3 (SOCS-3) in the homogenized fat were examined. Results Compared with the DIO-R group, DIO model group's body weight, NPY significantly increased (P<0.01);leptin in the serum and homogenized fat decreased (P<0.05);SOCS-3 increased (P<0.05). After drug intervention, weight of each drug group declined. Compared with the DIO model group, Jianpi Liqi group's leptin in the homogenized fat increased (P<0.05). Shengqing group's leptin in homogenized fat increased, body weight reduced, NPY and SOCS-3 levels decreased, and better than sibutramine group and Jianpi Liqi group (P<0.05,P<0.01).Conclusion Shengqing herbs can reduce obesity and inhibit leptin resistance.

Acquired Immunodeficiency Syndrome ; prevention & control ; therapy ; Communicable Disease Control ; Humans